3,180
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Subgingival microbiota in a population with and without cognitive dysfunction

, , , , , , , & show all
Article: 1854552 | Received 20 Aug 2020, Accepted 17 Nov 2020, Published online: 15 Jan 2021

References

  • Prince M, Comas-Herrera A, Knapp M, et al. (2016). World Alzheimer report 2016 improving healthcare for people living with dementia: coverage, quality and costs now and in the future. Alzheimer’s Disease International (ADI), 1–8. Retrieved from https://www.alz.co.uk/research/world-report–2016
  • Scheltens P, Blennow K, Breteler MMB, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–517.
  • Imtiaz B, Tolppanen AM, Kivipelto M, et al. Future directions in Alzheimer’s disease from risk factors to prevention. Biochem Pharmacol. 2014;88(4):661–670.
  • Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819–828.
  • Panza F, Lozupone M, Solfrizzi V, et al. Time to test antibacterial therapy in Alzheimer’s disease. Brain. 2019. DOI:https://doi.org/10.1093/brain/awz244
  • Sochocka M, Donskow-Łysoniewska K, Diniz BS, et al. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease—a critical review. Mol Neurobiol. 2019;56(3):1841–1851.
  • Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer’s disease. J Neurogastroenterol Motil. 2019;25(1):48–60.
  • Kamer AR, Craig RG, Niederman R, et al. Periodontal disease as a possible cause for Alzheimer’s disease. Periodontol 2000. 2020;83(1):242–271.
  • Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013;7(5):1016–1025.
  • Hong BY, Araujo MVF, Strausbaugh LD, et al. Microbiome profiles in periodontitis in relation to host and disease characteristics. PLoS ONE. 2015;10(5):1–14.
  • Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:1–14.
  • Schmidt TSB, Hayward MR, Coelho LP, et al. Extensive transmission of microbes along the gastrointestinal tract. Elife. 2019;8. DOI:https://doi.org/10.7554/eLife.42693.
  • Kamer AR, Craig RG, Pirraglia E, et al. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects. J Neuroimmunol. 2009;216(1–2):92–97.
  • Noble JM, Scarmeas N, Celenti RS, et al. Serum IgG antibody levels to periodontal microbiota are associated with incident alzheimer disease. PLoS ONE. 2014;9(12):1–14.
  • Olsen I, Yamazaki K. Can oral bacteria affect the microbiome of the gut? J Oral Microbiol. 2019;11(1):1586422.
  • Holmer J, Eriksdotter M, Schultzberg M, et al. Association between periodontitis and risk of Alzheimer′s disease, mild cognitive impairment and subjective cognitive decline: A case–control study. J Clin Periodontol. 2018;45(11):1287–1298.
  • Field N, Cohen T, Struelens MJ, et al. Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis. 2014;14(4):341–352.
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7(3):263–269.
  • Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med. 2004;256(3):240–246.
  • Jessen F. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):3–7.
  • Pereira PAB, Aho VTE, Paulin L, et al. Oral and nasal microbiota in Parkinson’s disease. Parkinsonism Related Disord. 2017;38:61–67.
  • Aho VTE, Pereira PAB, Voutilainen S, et al. Gut microbiota in Parkinson’s disease: temporal stability and relations to disease progression. EBioMedicine. 2019;44:691–707.
  • Somervuo P, Koskinen P, Mei P, et al. BARCOSEL: A tool for selecting an optimal barcode set for high-throughput sequencing. BMC Bioinf. 2018;19(1):4–9.
  • Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10.
  • Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–7541.
  • Kozich JJ, Westcott SL, Baxter NT, et al. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112–5120.
  • Mothur MiSeq SOP [Internet]. [cited 2018 Mar 18]. Available from: https://www.mothur.org/wiki/MiSeq_SOP
  • Chen T, Yu WH, Izard J, et al. The human oral microbiome database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database J Bio Databases Curation. 2010;2010:1–10.
  • Davis NM, Proctor DM, Holmes SP, et al. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6(1):1–39.
  • McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217.
  • Oksanen J, Blanchet FG, Friendly M, et al. Vegan: community ecology package. R Package Version. 2019;2:5–6.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.
  • Bosshardt DD. The periodontal pocket: pathogenesis, histopathology and consequences. Periodontol 2000. 2017;76:43–50.
  • Feres M, Teles F, Teles R, et al. The subgingival periodontal microbiota of the aging mouth. Periodontol 2000. 2016;72(1):30–53.
  • Griffen AL, Beall CJ, Campbell JH, et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012;6(6):1176–1185.
  • Cockburn AF, Dehlin JM, Ngan T, et al. High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia. Investig Genet. 2012;3(1):19.
  • Vogt NM, Kerby RL, Dill-McFarland KA, et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017;7(1):1–11.
  • Vacca M, Celano G, Calabrese FM, et al. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8(4):1–25.
  • Poole S, Singhrao SK, Kesavalu L, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36(4):665–677.
  • Miklossy J. Alzheimer’s disease - a neurospirochetosis. analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflammation. 2011;8(1):90.
  • Mason MR, Preshaw PM, Nagaraja HN, et al. The subgingival microbiome of clinically healthy current and never smokers. ISME J. 2015;9(1):268–272.
  • Jervøe-Storm P-M, AlAhdab H, Koltzscher M, et al. Comparison of curet and paper point sampling of subgingival bacteria as analyzed by real-time polymerase chain reaction. J Periodontol. 2007;78(5):909–917.